Susceptibility of Staphylococcus aureus isolates to vancomycin at a University Hospital in Southern Brazil

Brazilian Journal of Microbiology

Volumn 37, Issue 3, 2006, Pages 244-246

  Lutz, Larissa ^a   Barth, Afonso Luís ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

h VISA; S. Aureus; Vancomycin; VISA

Indexed keywords

IMPATIENS; STAPHYLOCOCCUS AUREUS;

EID: 33845866866     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822006000300009     Document Type: Article

References (14)

1. Boyle-Vavra, S.; Berke, S.K.; Lee, J.C.; Daum, R.S. Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrob. Agents Chemother., 44(2), 272-277, 2000.
2. Cui, L.; Ma, X.; Sato, K.; Okuma, K.; Tenover, F.C.; Mamizuka, E.M.; Gemmell, C.G.; Kim, M-N.; Ploy, M.C.; Solh, N.E.; Ferraz, V.; Hiramatsu, K. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J. Clin. Microbiol., 41(1), 5-14, 2003.
3. Hiramatsu, K.; Aritaka, N.; Hanaki, H.; Kawasaki, S.; Hosoda, Y.; Hori, S.; Fukuchi, Y.; Kobayashi, I. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet, 350, 1670-1673, 1997.
4. Hiramatsu, K.; Hanaki, H.; Ino, T.; Yabuta, K.; Oguri, T.; Tenover, F.C. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother., 40, 135-146, 1997.
5. Hiramatsu, K. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect. Dis., 1, 147-155, 2001.
6. Hubert, S.K.; Mohammed, J.M.; Fridkin, S.K.; Gaynes, R.P.; McGowan, J.E. Jr.; Tenover, F.C. Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals. J. Clin. Microbiol., 37(11), 3590-3593, 1999.
7. Kaufmann, M.E.; Pitt, T.L. Pulsed-field gel electrophoresis of bacterial DNA. In: Chart, H. (ed). Methods in Practical Laboratory Bacteriology. CRC Press, London, 1994, p.83-92.
8. Kloos, W.E.; Bannerman, T.L. Staphylococcus and Micrococcus. In: Murray, P.R.; Baron, E.J.; Pfaller, M.A.; Tenover, F.C.; Yolken, R.H. (ed). Manual of Clinical Microbiology. American Society for Microbiology, Washington, DC, 1999, p.264-282.
9. NCCLS. Performance standards for antimicrobial susceptibility testing. Twelfth Informational Supplement M100-S12. National Committee for Clinical Laboratory Standards, Villanova, PA. 2002.
10. Paulsen, I.T.; Firth, N.; Skurray, R.A. Resistance to antimicrobial agents other than beta-lactams. In: Crossley, K.B.; Archer, G.L. (ed). The staphylococci in human disease. Churchill Livingstone, New York, N. Y., 1997, p.175-212.
11. Tenover, F.C.; Arbeit, R.D.; Goering, R.V.; Mickelsen, P.A.; Murray, B.E.; Persing, D.H.; Swaminathan, B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33, 2233-2239, 1995.
12. Tenover, F.C.; Biddle, J.W.; Lancaster, M.V. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg. Infect. Dis., 7(2), 327-332, 2001.
13. Wenzel, R.P.; Nettleman, M.D.; Jones, R.N.; Pfaller, M.A. Methicillin-resistant Staphylococcus aureus: implications for the 1990s and effective control measures. Am. J. Med., 91(3B), 2215-2275, 1991.
14. Whitener, C.J.; Park, S.Y.; Browne, F.A.; Browne, F.A.; Parent, L.J.; Julian, K.; Bozdogan, B.; Appelbaum, P.C.; Chaitram, J.; Weigel, L.M.; Jernigan, J.; McDougal, L.K.; Tenover, F.C.; Fridkin, F.K. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin. Inf. Dis., 38, 1049-55, 2004.